Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
2018
Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
12
Citations
NaN
KQI